Xenova preclinical data

XNVAY presented data on its XR5118 blocker of plasminogen activator inhibitor (PAI). As reported at

Read the full 159 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE